Giudice, A.; Antonelli, A.; Chiarella, E.; Baudi, F.; Barni, T.; Di Vito, A.
The Case of Medication-Related Osteonecrosis of the Jaw Addressed from a Pathogenic Point of View. Innovative Therapeutic Strategies: Focus on the Most Recent Discoveries on Oral Mesenchymal Stem Cell-Derived Exosomes. Pharmaceuticals 2020, 13, 423.
https://doi.org/10.3390/ph13120423
AMA Style
Giudice A, Antonelli A, Chiarella E, Baudi F, Barni T, Di Vito A.
The Case of Medication-Related Osteonecrosis of the Jaw Addressed from a Pathogenic Point of View. Innovative Therapeutic Strategies: Focus on the Most Recent Discoveries on Oral Mesenchymal Stem Cell-Derived Exosomes. Pharmaceuticals. 2020; 13(12):423.
https://doi.org/10.3390/ph13120423
Chicago/Turabian Style
Giudice, Amerigo, Alessandro Antonelli, Emanuela Chiarella, Francesco Baudi, Tullio Barni, and Anna Di Vito.
2020. "The Case of Medication-Related Osteonecrosis of the Jaw Addressed from a Pathogenic Point of View. Innovative Therapeutic Strategies: Focus on the Most Recent Discoveries on Oral Mesenchymal Stem Cell-Derived Exosomes" Pharmaceuticals 13, no. 12: 423.
https://doi.org/10.3390/ph13120423
APA Style
Giudice, A., Antonelli, A., Chiarella, E., Baudi, F., Barni, T., & Di Vito, A.
(2020). The Case of Medication-Related Osteonecrosis of the Jaw Addressed from a Pathogenic Point of View. Innovative Therapeutic Strategies: Focus on the Most Recent Discoveries on Oral Mesenchymal Stem Cell-Derived Exosomes. Pharmaceuticals, 13(12), 423.
https://doi.org/10.3390/ph13120423